Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ros

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Anales Espanoles De Pediatria|September 27, 2000
[Acute interstitial nephritis of probable pharmacological origin]A Giménez Llort, J Villanueva Lamas, J Ros Viladoms, et al.
Head & Neck|June 22, 1999
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapyA de Graeff, R J de Leeuw, W J Ros, et al.
Medicina Clinica|April 13, 1991
[Microalbuminuria in essential arterial hypertension]J Redón, J M Pascual, A Miralles, et al.
Revista Espanola De Cardiologia|August 1, 1990
[The Fuenlabrada's study: tobacco as cardiovascular risk factor in children and adolescents]I Plaza, R P Mariscal, J Ros-Jellici, et al.
Neurocirugia (Asturias, Spain)|March 13, 2008
Cavernomas in children with brain tumors: a late complication of radiotherapyJ F Martínez-Lage, I de la Fuente, J Ros de San Pedro, et al.
Hepatology (Baltimore, Md.)|August 30, 2001
Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitisP Cejudo-Martín, J Ros, M Navasa, et al.
Revista Espanola De Cardiologia|April 1, 1990
[Fuenlabrada study: lipid and lipoprotein levels in children and adolescents associated with ischemic cardiopathy prevalence among their relatives]I Plaza, R P Mariscal, M T Muñoz, et al.
Revista Espanola De Cardiologia|November 1, 1989
[The Fuenlabrada study: arterial pressure in children and adolescents]I Plaza, M T Muñoz, J Otero, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinationsJ Ros, V Navarro, G Villacampa, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic ratsW Jiménez, C S Gal, J Ros, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Anales Espanoles De Pediatria|September 27, 2000
[Acute interstitial nephritis of probable pharmacological origin]A Giménez Llort, J Villanueva Lamas, J Ros Viladoms, et al.
Head & Neck|June 22, 1999
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapyA de Graeff, R J de Leeuw, W J Ros, et al.
Medicina Clinica|April 13, 1991
[Microalbuminuria in essential arterial hypertension]J Redón, J M Pascual, A Miralles, et al.
Revista Espanola De Cardiologia|August 1, 1990
[The Fuenlabrada's study: tobacco as cardiovascular risk factor in children and adolescents]I Plaza, R P Mariscal, J Ros-Jellici, et al.
Neurocirugia (Asturias, Spain)|March 13, 2008
Cavernomas in children with brain tumors: a late complication of radiotherapyJ F Martínez-Lage, I de la Fuente, J Ros de San Pedro, et al.
Hepatology (Baltimore, Md.)|August 30, 2001
Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitisP Cejudo-Martín, J Ros, M Navasa, et al.
Revista Espanola De Cardiologia|April 1, 1990
[Fuenlabrada study: lipid and lipoprotein levels in children and adolescents associated with ischemic cardiopathy prevalence among their relatives]I Plaza, R P Mariscal, M T Muñoz, et al.
Revista Espanola De Cardiologia|November 1, 1989
[The Fuenlabrada study: arterial pressure in children and adolescents]I Plaza, M T Muñoz, J Otero, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinationsJ Ros, V Navarro, G Villacampa, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic ratsW Jiménez, C S Gal, J Ros, et al.
Pageof 18